• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Wiki HELP! Q code for an Anti-emetic Infusion

DanielleKiehl

Networker
Messages
27
Location
Richfield, OH
Best answers
0
Medicare is requiring us to bill out our INFUSION of an anti-emetic (given with chemotherapy) as a Q code. Unfortunatly i can only locate a Q code for ORAL administration. Any suggestions???

Thanks for your PROMPT help :)

-Dani
 
Not my area of expertise but have you looked at J8597?

Ohh...wait-you needed a Q code. I'll see what I can find if someone doesn't beat me to it.

Let me try this again...have you looked at Q0163-Q0181?
 
Last edited:
Medicare is requiring us to bill out our INFUSION of an anti-emetic (given with chemotherapy) as a Q code. Unfortunatly i can only locate a Q code for ORAL administration. Any suggestions???

Thanks for your PROMPT help :)

-Dani

Just a thought - has your carrier changed recently? We have found that our new carrier is requesting some really odd coding and have to take it to a higher level to get things straightened out. Sometimes they processed it wrong (hard to believe...)
 
I wonder if you're going to have to go with the Q0081 code for the IV anti-emetic. (but it's not allowed to be billed with more than one unit per visit)-I can't find another Qcode for IV anti-emetic - all the others ones seem to be a oral now, a "substitute" for the IV.
{that's my opinion on the posted matter}
 
I hope these codes work for you; this is not my area of expertise-

Q0177 Hydroxyzine pamoate, 25 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0178 Hydroxyzine pamoate, 50 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0164 Prochlorperazine maleate, 5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0165 Prochlorperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0166 Granisetron HCl, 1 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Q0167 Dronabinol, 2.5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0168 Dronabinol, 5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0169 Promethazine HCl, 12.5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0170 Promethazine HCl, 25 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0171 Chlorpromazine HCl, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0172 Chlorpromazine HCl, 25 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0173 Trimethobenzamide HCl, 250 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0174 Thiethylperazine maleate, 10 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0175 Perphenzaine, 4 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0179 Ondansetron HCl 8 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Q0180 Dolasetron mesylate, 100 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen
 
Top